Project Grant R01MH145082
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a Project Grant totaling $192,192 under the Mental Health Research Grants program (CFDA 93.242) on April 15, 2026, with completion targeted for March 31, 2031. The award supports development of an artificial intelligence foundation model designed to advance personalized treatment prediction, treatment stratification, and biotype discovery for Major Depressive Disorder (MDD)...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a Project Grant of $721,645 under the Mental Health Research Grants program (CFDA 93.242) effective May 1, 2026, through January 31, 2031. This research initiative aims to develop accurate and robust multimodal prognostic markers for psychosis transition in youth at clinical high risk using an artificial intelligence (AI)-driven computational framework. The project leverages...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a $744,121 Project Grant (CFDA 93.242: Mental Health Research Grants) effective July 14, 2025, through April 30, 2030, to develop Foundation Models (FMs) for human functional neuroimaging with applications to psychiatric disorders. The research initiative aims to create an integrated framework combining foundation models with explainable artificial intelligence (XAI)...
- Federal Grant Award Summary Massachusetts General Hospital's Research Management Division received a $790,560 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective April 1, 2026 through March 31, 2030. The award funds research to develop advanced artificial intelligence (AI) models that predict differential responses to antidepressant treatments by integrating electronic health record (EHR) data with genomic...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a $1.07 million Project Grant under the Mental Health Research Grants program (CFDA 93.242) on April 1, 2026, with completion scheduled for January 31, 2028. This research grant supports the development and validation of a personalized intermittent theta-burst stimulation (ITBS) protocol for treating treatment-resistant depression (TRD) by utilizing prefrontal...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Regents of the University of California, San Francisco a Project Grant of $458,177 under the Mental Health Research Grants program (CFDA 93.242) for the period June 9, 2025 through June 8, 2027. The research project, titled "Leveraging Population Level Data to Inform Prevention and Treatment of Adolescent Depression Following Social Adversities," addresses the significant gap between current...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $759,816 to the University of California, Berkeley under the Mental Health Research Grants program (CFDA 93.242) beginning May 1, 2026 and extending through January 31, 2031. This Project Grant funds the development, application, and dissemination of targeted machine learning estimators (TMLEs) designed to address critical analytical challenges in cluster randomized trials (CRTs) evaluating HIV prevention...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $818,253 to The Regents of the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) beginning July 1, 2025, and extending through April 30, 2030. This Project Grant supports a five-year research investigation examining neuromodulatory system abnormalities in late-life depression (LLD), with specific focus on the associations between structural and functional brain...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded J. David Gladstone Institutes a Project Grant totaling $2,177,199 under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025, through August 31, 2027. This two-phase, milestone-driven research initiative aims to develop and validate a novel humanized microglia-neural cell (HUMGN) mouse model that incorporates human microglia, neurons, and astrocytes differentiated from induced...
- Federal Grant Award Summary The University of South Carolina received a $1,016,319 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2026, with completion targeted for April 30, 2031. The project, titled "Multimodal AI for Monitoring and Predicting Neurocognitive Impairment in People with HIV," will develop and apply artificial intelligence methodologies to advance precision...
The National Institute of Mental Health (NIMH) awarded a $722,773 Project Grant to The Leland Stanford Junior University on July 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support research on explainable artificial intelligence (XAI) for predicting depression in people with HIV (PWH). The project, scheduled for completion by March 31, 2031, addresses the critical clinical need to improve depression identification and management in PWH, a population experiencing major depressive disorder (MDD) at rates 3 times higher than the general population. The research will deliver an innovative XAI framework using knowledge graphs and multimodal data integration to elucidate the neurobiological, cognitive, sociodemographic, and environmental determinants underlying depression in PWH, with particular emphasis on interpretability to support clinical decision-making. The project leverages prospective longitudinal data from 3,962 PWH across multiple existing studies, which will be harmonized to the National NeuroHIV Tissue Consortium repository to maximize research efficiency. By moving beyond conventional single-study analyses, the Stanford team will create an integrated, interpretable predictive model that captures bidirectional associations between depressive symptoms, immune dysregulation, and inflammatory markers in virally suppressed individuals. The deliverables will advance understanding of the overlapping symptomatology between depression, HIV infection, and antiretroviral therapy side effects, ultimately enabling more accurate identification and management of depression in this high-risk population.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $722.8k | 7/16/26 |